Status:
UNKNOWN
Iron Deficiency as an Ignored Cause of Infertility
Lead Sponsor:
Dextra Fertility Clinic
Conditions:
Iron Deficiency
Infertility
Eligibility:
FEMALE
18-42 years
Phase:
PHASE4
Brief Summary
Iron deficiency may play a critical role in human infertility, oocyte quality and may even play a role in endometrial receptivity. By correcting iron deficiency, low ferritin values, in infertile wome...
Eligibility Criteria
Inclusion
- Patient's 18 to 42 years and in full consent
- Ferritin ≤ 30 ug/l
- Anti-mullerian hormone (AMH) \> 1ug/l
- Planned for IVF/ ICSI treatment
- Diagnosis for treatment: tubal factor, male factor or unexplained infertility (NUD)
Exclusion
- Endometriosis
- Poor responder
- Inflammatory bowel disease (IBD), colitis ulcerosa
- Rheumatoid arthritis
- Renal insufficiency
- Cardiac insufficiency
- Body Mass Index (BMI) over 35
- Known hypersensitivity to the active substance, to ferric carboxymaltose or any of its excipients, or to other parental iron products
- Clinical evidence of iron overload or disturbances in the utilization of iron
- use of atosiban or filgrastim during stimulation or embryo transfer
Key Trial Info
Start Date :
August 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2022
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT04510870
Start Date
August 17 2020
End Date
February 28 2022
Last Update
August 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dextra Fertility Clinic
Helsinki, Finland, 00180